NIH-funded research NIH-funded research

Improving the infrastructure of the Advanced Technology Research Facility.

Official title: THE COST PLUS FIXED FEE (CPFF) TO TO REFURBISH AND IMPROVE NCI FREDERICK INFRASTRUCTURE WILL HAVE A BASE AND THREE (3) OPTIONS.

Funded at Leidos Biomedical Research, INC. · NIH-10941348 · Data updated 2026-11-12

This study is all about upgrading a research facility's computer and storage systems to help scientists do their work better, which could eventually lead to new treatments and improvements for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLeidos Biomedical Research, INC.
NIH-funded
Lab location1 site (Frederick, United States)
Project startSeptember 27, 2023
Project endJuly 10, 2026
Funding year2023
Award (this year)$8,411,190
NIH project number75N91019D00024-0-759102300024-1
Project IDNIH-10941348 on NIH RePORTER

Who could benefit from this research

Could help

Patients involved in research studies utilizing the enhanced infrastructure may benefit from more advanced and efficient research outcomes.

Less likely to help

Patients not participating in research studies or those outside the scope of the facility's research focus may not receive direct benefits.

What this research studies

This project focuses on enhancing the Advanced Technology Research Facility's Data Center by completing its build-out to accommodate additional computing and storage resources. The work will be conducted in two phases, with the first phase involving the installation of new racks, cooling units, and necessary power and HVAC systems. This upgrade aims to ensure that the facility can support advanced research activities effectively. Patients may benefit indirectly from improved research capabilities that arise from this enhanced infrastructure.

Why it matters

Potential benefit: If successful, this project could lead to improved research capabilities that may ultimately enhance patient care and treatment options.

How similar studies have gone: This project is focused on infrastructure improvement and does not directly relate to patient outcomes; thus, it does not have a precedent in similar studies.

Where this research is happening

  • Leidos Biomedical Research, INC.
    Frederick, United States
    Active

Researchers

  • Principal investigator: Pendleton, Richard — Leidos Biomedical Research, INC.
  • Study coordinator: Pendleton, Richard

Related research

Other NIH-funded projects on the same topics.

  • Improving public health responses to COVID-19 through standardized testing.

    This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11220317

  • Creating a large library of cancer models for research use

    This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219823

  • Advancing global cancer control through data analysis and international collaboration

    This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219804

  • Support for HIV and HPV cancer prevention clinical trials in the Americas

    This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219802

  • Development and production of clinical-grade biopharmaceuticals

    This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219801

  • Understanding the immune response to COVID-19

    This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219800

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.